Works matching IS 10781552 AND DT 2024 AND VI 30 AND IP 6
Results: 23
Investigating effective methods of clinical pharmacy training on oncology for community pharmacists: An observational study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1041, doi. 10.1177/10781552231200427
- By:
- Publication type:
- Article
Managing opioids and mitigating opioid risks in patients with cancer: An environmental scan of the attitudes, confidence, and practices of ambulatory, community and hospital pharmacists practicing in Canada.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1029, doi. 10.1177/10781552231200169
- By:
- Publication type:
- Article
Acute renal failure during cisplatin-based chemotherapy: A prospective monocentric study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1023, doi. 10.1177/10781552231199984
- By:
- Publication type:
- Article
Cost burden of chemotherapy for Indonesian healthcare insurance and social security/Jaminan Kesehatan Nasional (JKN) patients with non-Hodgkin lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1096, doi. 10.1177/10781552241261250
- By:
- Publication type:
- Article
Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1016, doi. 10.1177/10781552231199048
- By:
- Publication type:
- Article
A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1122, doi. 10.1177/10781552241258175
- By:
- Publication type:
- Article
Pembrolizumab-induced type 1 diabetes.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1118, doi. 10.1177/10781552241255699
- By:
- Publication type:
- Article
Advancements in the use of nanopharmaceuticals for cancer treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1078, doi. 10.1177/10781552241251757
- By:
- Publication type:
- Article
Imatinib-induced ulcerative colitis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1111, doi. 10.1177/10781552241255290
- By:
- Publication type:
- Article
Acute pancreatitis associated with pembrolizumab-induced hypertriglyceridemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1101, doi. 10.1177/10781552241245332
- By:
- Publication type:
- Article
A comparative review of Aphexda and Mozobil for mobilization prior to stem cell collection.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1073, doi. 10.1177/10781552241247472
- By:
- Publication type:
- Article
Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1089, doi. 10.1177/10781552241242022
- By:
- Publication type:
- Article
Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1084, doi. 10.1177/10781552241241493
- By:
- Publication type:
- Article
Dose reduction and toxicity of lenalidomide-dexamethasone in multiple myeloma: A machine-learning prediction model.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1051, doi. 10.1177/10781552231200795
- By:
- Publication type:
- Article
Review of drug-drug interactions in patients with prostate cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1057, doi. 10.1177/10781552241238198
- By:
- Publication type:
- Article
Evaluation of proteinuria monitoring practice patterns and treatment implications in patients with cancer receiving bevacizumab products.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1010, doi. 10.1177/10781552231198779
- By:
- Publication type:
- Article
Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 999, doi. 10.1177/10781552231194077
- By:
- Publication type:
- Article
Late-onset cardiotoxicity in patients with HER2-positive metastatic breast cancer receiving trastuzumab-based therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 992, doi. 10.1177/10781552231193149
- By:
- Publication type:
- Article
Optimizing cyclosporine A dose post allogeneic hematopoietic stem cell transplantation in paediatric cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 983, doi. 10.1177/10781552231192516
- By:
- Publication type:
- Article
DPD deficiency in an Irish oncology centre: Prevalence and clinical implications.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 977, doi. 10.1177/10781552231192107
- By:
- Publication type:
- Article
Safety outcomes of rapid- versus standard-infusion rate oxaliplatin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 971, doi. 10.1177/10781552231192007
- By:
- Publication type:
- Article
Evaluation of glycopeptide prescription in high-risk febrile neutropenia: A monocentric study of North Africa.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 964, doi. 10.1177/10781552231191718
- By:
- Publication type:
- Article
Adverse events associated with Pegaspargase biosimilar in pediatric patients with acute lymphoblastic leukemia: A prospective single-center study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 958, doi. 10.1177/10781552231190827
- By:
- Publication type:
- Article